David Anderson
Chief Tech/Sci/R&D Officer bei VBI VACCINES INC.
Vermögen: 2 979 $ am 31.03.2024
Profil
David Evander Anderson was the founder of Variation Biotechnologies (US), Inc. founded in 2001 where he held the title of Vice President-Immunology & Research.
He is also the founder of Variation Biotechnologies, Inc. (Canada).
Currently, Dr. Anderson holds the position of Chief Scientific Officer at VBI Vaccines, Inc. since 2016 and at VBI Vaccines (Delaware), Inc. since 2015.
Previously, he worked as an Assistant Professor at Harvard Medical School in 2009 and as the Chief Scientific Officer & Senior VP-Research at VBI Vaccines, Inc. Dr. Anderson received his doctorate degree from Harvard University in 1999 and his undergraduate degree from the University of California, Davis.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VBI VACCINES, INC.
0,02% | 27.07.2023 | 4 940 ( 0,02% ) | 2 979 $ | 31.03.2024 |
Aktive Positionen von David Anderson
| Unternehmen | Position | Beginn |
|---|---|---|
| VBI VACCINES INC. | Chief Tech/Sci/R&D Officer | 06.05.2016 |
VBI Vaccines (Delaware), Inc.
 VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Chief Tech/Sci/R&D Officer | 01.08.2015 |
Ehemalige bekannte Positionen von David Anderson
| Unternehmen | Position | Ende |
|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | 01.02.2009 |
Variation Biotechnologies, Inc. (Canada)
 Variation Biotechnologies, Inc. (Canada) BiotechnologyHealth Technology Variation Biotechnologies, Inc. (Canada) is a Canadian company that was founded by David Evander Anderson and is part of VBI Vaccines, Inc. The private company is based in Ottawa, Canada and engages in the manufacture of vaccines. | Founder | - |
| VBI VACCINES INC | Chief Tech/Sci/R&D Officer | - |
Variation Biotechnologies (US), Inc.
 Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Founder | - |
Ausbildung von David Anderson
| Harvard University | Doctorate Degree |
| University of California, Davis | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VBI VACCINES INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Health Technology |
Variation Biotechnologies, Inc. (Canada)
Variation Biotechnologies, Inc. (Canada) BiotechnologyHealth Technology Variation Biotechnologies, Inc. (Canada) is a Canadian company that was founded by David Evander Anderson and is part of VBI Vaccines, Inc. The private company is based in Ottawa, Canada and engages in the manufacture of vaccines. | Health Technology |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Health Technology |
VBI Vaccines, Inc. /Old/
 VBI Vaccines, Inc. /Old/ BiotechnologyHealth Technology VBI Vaccines, Inc. is a biopharmaceutical company. It engages in the development of eVLP vaccine platform for the design of (e) virus-like-particle vaccines that closely mimic the target virus. The company also involves in the development of thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI Vaccines was founded on July 25, 2014 and is headquartered in Cambridge, MA. | Health Technology |
